Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
Gastrointest Endosc. 2022 Jul;96(1):51-56. doi: 10.1016/j.gie.2022.02.051. Epub 2022 Mar 5.
Gastric plication involves inverting the stomach with tissue anchor placement to achieve serosa-to-serosa apposition. One potential application of gastric plication is the treatment of weight regain after Roux-en-Y gastric bypass (RYGB), a procedure also known as plication transoral outlet reduction (P-TORe). This study aims to assess technical feasibility, safety, and efficacy of P-TORe.
This was a registry study of RYGB patients who underwent P-TORe for weight regain. The primary outcome was the amount of weight loss and clinical success rate, defined as percentage of total weight loss (TWL) of at least 5% at 12 months. Secondary outcomes were technical success, adverse events (AEs), and predictors of weight loss.
One hundred eleven RYGB patients underwent P-TORe. Average body mass index (BMI) was 38.5 ± 7.5 kg/m. Baseline gastrojejunal anastomosis (GJA) and pouch sizes were 17 ± 6 mm and 5 ± 2 cm, respectively. The primary outcome was total weight loss, defined as patients experiencing 9.5% ± 8.5% TWL at 12 months. Clinical success rate was 73%. Technical success rate was 100%. Argon plasma coagulation (APC) was performed around the GJA in all patients (100%) before plication placement. The total number of plications per case was 7 ± 3. Overall AE rate was 12.6%. These included GJA stenosis (9.9%), melena because of marginal ulceration (1.8%), and deep vein thrombosis (.9%). The severe AE rate was 0%. Predictors of weight loss were the amount of weight regain and baseline pouch length.
This novel P-TORe technique combining APC with gastric plication appears to be technically feasible, safe, and effective at treating weight regain after RYGB.
胃折叠术涉及用组织锚钉将胃翻转,以实现浆膜对浆膜的贴合。胃折叠术的一个潜在应用是治疗 Roux-en-Y 胃旁路术(RYGB)后的体重反弹,该手术也称为折叠经口出口缩小术(P-TORe)。本研究旨在评估 P-TORe 的技术可行性、安全性和疗效。
这是一项对接受 P-TORe 治疗 RYGB 后体重反弹的患者进行的 RYGB 患者注册研究。主要结局是体重减轻量和临床成功率,定义为 12 个月时总体重减轻率(TWL)至少 5%。次要结局是技术成功率、不良事件(AE)和体重减轻的预测因素。
111 例 RYGB 患者接受了 P-TORe。平均体重指数(BMI)为 38.5±7.5kg/m。基线胃空肠吻合口(GJA)和囊袋大小分别为 17±6mm 和 5±2cm。主要结局是总体重减轻,定义为患者在 12 个月时经历 9.5%±8.5%的 TWL。临床成功率为 73%。技术成功率为 100%。所有患者(100%)在折叠放置前均在 GJA 周围进行氩等离子凝固(APC)。每个病例的折叠总数为 7±3。总体 AE 发生率为 12.6%。这些包括 GJA 狭窄(9.9%)、因边缘溃疡导致的黑便(1.8%)和深静脉血栓形成(0.9%)。严重 AE 发生率为 0%。体重减轻的预测因素是体重反弹量和基线囊袋长度。
这种将 APC 与胃折叠术相结合的新型 P-TORe 技术在治疗 RYGB 后体重反弹方面似乎具有技术可行性、安全性和有效性。